scholarly journals Case reports Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome – effective treatment with tocilizumab

2015 ◽  
Vol 3 ◽  
pp. 157-160 ◽  
Author(s):  
Małgorzata Kwiatkowska ◽  
Ewa Jednacz ◽  
Lidia Rutkowska-Sak
2001 ◽  
Vol 42 (1) ◽  
pp. 80-83 ◽  
Author(s):  
T. Tikkakoski ◽  
M. Leppänen ◽  
J. Turunen ◽  
S. Anderson ◽  
H. Södervik

2019 ◽  
Vol 11 (3) ◽  
pp. 281-291
Author(s):  
Wang-ning Zhang ◽  
Liu Yang ◽  
Sheng-sheng He ◽  
Ai-ping Li ◽  
Xue-mei Qin

2015 ◽  
Vol 55 (1) ◽  
pp. 75-78 ◽  
Author(s):  
Teresa Cristina M.V. Robazzi ◽  
Gabriela Rios ◽  
Catarina Castro

1998 ◽  
Vol 173 (S35) ◽  
pp. 64-70 ◽  
Author(s):  
John H. Greist ◽  
James W. Jefferson

Background Pharmacotherapy for obsessive-compulsive disorder (OCD) was seldom beneficial before clomipramine, a potent selective serotonin reuptake inhibitor (SSRI), became available. Subsequent progress in pharmacotherapy for OCD has increased the possibility of effective treatment for most sufferers.Method Randomised controlled trials of pharmacotherapy for OCD were reviewed, as well as reports of beneficial pharmacotherapy found in open trials and case reports.Results SSRIs are well-tolerated by patients with OCD, even in large doses. Prose roto n erg i c augmentation is seldom helpful but antipsychotic augmentations seem beneficial for many OCD patients with comorbid tics.Conclusions Potent SSRIs are the pharmacotherapy of choice for OCD, with a more limited role reserved for monoamine oxidase inhibitors. If one SSRI is ineffective, others may be beneficial. Non-drug therapies are also important in OCD: behaviour therapy is frequently helpful but infrequently available and neurosurgery is sometimes helpful when all other treatments have failed.


2009 ◽  
Vol 98 (5) ◽  
pp. 1055-1061
Author(s):  
Naoki Takahashi ◽  
Hideki Kimura ◽  
Kenji Kasuno ◽  
Daisuke Mikami ◽  
Hironobu Naiki ◽  
...  

2010 ◽  
Vol 25 (10) ◽  
pp. 2175-2177 ◽  
Author(s):  
Shuichi Ito ◽  
Akiko Tsutsumi ◽  
Tomonori Harada ◽  
Aya Inaba ◽  
Shuichiro Fujinaga ◽  
...  

1966 ◽  
Vol 112 (484) ◽  
pp. 309-319 ◽  
Author(s):  
M. G. Gelder ◽  
I. M. Marks

Severe agoraphobia is difficult to treat. Encouraging immediate results have been reported with diverse treatments, including intensive psychotherapy (Friedman, 1959), acetyl choline injections (Sim, 1964), antidepressant drugs (King, 1962) and more recently with behaviour therapy (Wolpe, 1958). It is this latter claim which this paper examines. Early reports (e.g. Meyer, 1957; Wolpe, 1958) suggested that behaviour therapy might prove to be a rapid and effective treatment, but a small series studied by Meyer and Gelder (1963) demonstrated that results were not always as effective as single case reports suggested, and showed clearly that the treatment was often lengthy, taking 80 hours on the average. A retrospective investigation of a larger series (Marks and Gelder, 1965; Cooper, Gelder and Marks, 1965) again failed to support the early claims, although it was shown that behaviour therapy is an effective treatment for circumscribed phobias such as fears of animals and insects.


Sign in / Sign up

Export Citation Format

Share Document